Replimune Group, Inc. (REPL)
7.12
+0.08
(+1.14%)
USD |
NASDAQ |
Jan 20, 15:15
Replimune Group Market Cap: 558.52M for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Rapt Therapeutics, Inc. | 951.67M |
| Olema Pharmaceuticals, Inc. | 1.841B |
| CorMedix, Inc. | 534.19M |
| Verastem, Inc. | 505.40M |
| Anavex Life Sciences Corp. | 446.74M |
Market Cap Related Metrics
| PEG Ratio | -0.1252 |
| Price to Book Value | 2.121 |
| Price | 7.12 |
| Earnings Yield | -50.67% |
| PEGY Ratio | -0.1252 |